Form 8-K - Current report:
SEC Accession No. 0001193125-24-218828
Filing Date
2024-09-13
Accepted
2024-09-13 16:00:34
Documents
21
Period of Report
2024-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d878816d8k.htm   iXBRL 8-K 36224
2 EX-1.1 d878816dex11.htm EX-1.1 211426
3 EX-5.1 d878816dex51.htm EX-5.1 54311
4 EX-99.1 d878816dex991.htm EX-99.1 7435
5 EX-99.2 d878816dex992.htm EX-99.2 7488
10 GRAPHIC g878816g0913104141888.jpg GRAPHIC 5689
11 GRAPHIC g878816g0913104435217.jpg GRAPHIC 5661
12 GRAPHIC g878816g40i19.jpg GRAPHIC 3034
  Complete submission text file 0001193125-24-218828.txt   584135

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cnta-20240912.xsd EX-101.SCH 3284
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20240912_def.xml EX-101.DEF 14706
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20240912_lab.xml EX-101.LAB 24577
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20240912_pre.xml EX-101.PRE 15664
23 EXTRACTED XBRL INSTANCE DOCUMENT d878816d8k_htm.xml XML 6257
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 241297648
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)